Skip links

12th Clinical Biomarker & CDx Summit Europe, April 27–28, 2022, London, UK

OncoOne’s CEO Randolf Kerschbaumer will give a talk on “oxMIF as a novel biomarker and immuno-oncology therapeutic target for precision medicine”, at the 12th Clinical Biomarker & CDx Summit Europe; April 27–28, London, UK.

Home